Category: Drug Discovery
Drug Discovery market research reports by GlobalData
-
Microbiome-Targeting Therapeutics in Infectious Diseases - Thematic Research
Microbiome-Targeting Therapeutics in Infectious Diseases - Thematic Research Summary Microbiome-targeting drugs aim to alter the microbial composition of the gut through the administration of live microbes with the intention of regulating the human microbiome composition in a beneficial way that may ... Read More
-
Clinical Trials - Where are we Headed with COVID-19 Trials?
Clinical Trials - Where are we Headed with COVID-19 Trials? Summary This report provides an overview of global COVID-19 clinical trials extracted from the GlobalData Pharma Intelligence Center on March 30, 2022. The purpose of this report is to provide insight into the overall clinical trial landsca ... Read More
-
Smoking Cessation Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape
Smoking Cessation Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Smoking Cessation therapeutics. Synopsis In 2022, Nearly 350 million people will q ... Read More
-
Cartilage Repair Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
Cartilage Repair Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update Summary GlobalData's Medical Devices sector report, “Cartilage Repair Pipeline Report including Stages of Development, Segments, Region and Countries, Regu ... Read More
-
Hydrocephalus Shunts Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
Hydrocephalus Shunts Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update Summary GlobalData's Medical Devices sector report, “Hydrocephalus shunts Pipeline Report including Stages of Development, Segments, Region and Countri ... Read More
-
Neuroimmunology Drug Development - Thematic Research
Neuroimmunology Drug Development - Thematic Research Summary This report provides an overview of neuroimmunology drug development within eight key indications across eight pharmaceutical markets. The neuroimmune system is complex and a critical component in regulating nervous system health and disea ... Read More
-
Dysphagia Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update
Dysphagia Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update Summary This reports provides a data-driven overview of the current and future competitive landscape in Dysphagia therapeutics. Synopsis In 2022, there will be more than 182 million ... Read More
-
Anxiety Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update
Anxiety Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update Summary This reports provides a data-driven overview of the current and future competitive landscape in Anxiety therapeutics. Synopsis In 2022, there will be more than 291 million pre ... Read More
-
Alopecia Areata Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update
Alopecia Areata Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update Summary This reports provides a data-driven overview of the current and future competitive landscape in Alopecia areata therapeutics. Synopsis In 2022, there will be more than ... Read More
-
Pancreatic Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update
Pancreatic Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update Summary This reports provides a data-driven overview of the current and future competitive landscape in Pancreatic Cancer therapeutics. Synopsis In 2022, there will be more ... Read More
-
Small Cell Lung Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update
Small Cell Lung Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update Summary This reports provides a data-driven overview of the current and future competitive landscape in Small Cell Lung Cancer therapeutics. Synopsis In 2022, there wil ... Read More
-
Big Data in Pharmaceuticals - Thematic Research
Big Data in Pharmaceuticals - Thematic Research Summary This report provides an overview of the big data analytics in the pharma industry. Big data is generated in vast quantities across healthcare The healthcare and pharmaceutical industries generate data in abundance from a multitude of sources in ... Read More
-
T-Cell Lymphomas Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2020-2030
T-Cell Lymphomas Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2020-2030 Summary T-cell lymphomas (TCL) are white blood cell malignancies and a subtype of non-Hodgkin lymphomas (NHL), representin ... Read More
-
Hypercholesterolemia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Hypercholesterolemia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Hypercholesterolemia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, ... Read More
-
Diabetic Foot Ulcers Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Diabetic Foot Ulcers Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Diabetic Foot Ulcers Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, ... Read More
-
Osteosarcoma Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2021-2027
Osteosarcoma Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2021-2027 Summary This reports provides a data-driven overview of the current and future competitive landscape in osteosarcoma therapeutics. In osteosarcoma Cells expressing ganglioside GD2 ... Read More
-
Gastroparesis Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2021-2026
Gastroparesis Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2021-2026 Summary In gastroparesis Dopamine (D2) receptor is a major focus of drug developers. There are 17 drugs in the pipeline with 90% molecules present in early stage. Mid-sized Pharma ... Read More
-
Atopic Dermatitis - Epidemiology Analysis and Forecast, 2020-2030
Atopic Dermatitis - Epidemiology Analysis and Forecast, 2020-2030 Summary Atopic dermatitis (AD) is a chronic inflammatory skin disease characterized by itchy skin lesions and rashes. Although the condition affects people of all ages, it is primarily common among infants and children (Bowcock and Co ... Read More
-
Childhood Epilepsy Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2021-2027
Childhood Epilepsy Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2021-2027 Summary In Childhood Epilepsy Gamma-aminobutyric acid type A receptor (GABA(A) receptor) is a major focus of drug developers. There are 27 drugs in the pipeline with 79% mole ... Read More
-
Bipolar Disorder - Global Drug Forecast and Market Analysis to 2030
Bipolar Disorder - Global Drug Forecast and Market Analysis to 2030 Summary Bipolar disorder, known originally as manic-depressive illness, is a mental disorder characterized by periods of mania and depression. Manic episodes are the distinguishing feature of this condition and consist of an abnorma ... Read More
-
Eosinophilic Esophagitis - Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Stratergies and Forecast, 2020 - 2030
Eosinophilic Esophagitis - Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Stratergies and Forecast, 2020 - 2030 Summary Eosinophilic Esophagitis (EoE) is defined as a chronic, immune-mediated, atopic inflammatory conditio ... Read More
-
T-Cell Lymphomas - Epidemiology Forecast to 2030
T-Cell Lymphomas - Epidemiology Forecast to 2030 Summary TCL are a rare type of cancer that form in T-cells and are either indolent (slow-growing) or aggressive. TCL either develops in lymphoid tissues such as the lymph nodes and spleen, or in other organs (gastrointestinal tract, liver, nasal cavit ... Read More
Research Assistance
